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ties of both host and virus gene expression. This study shows that the transcriptional activity of
myocardin in regulating cardiomyocyte hypertrophy is enhanced by co-expressing CMV IE2. Forced
expression of IE2 increases the augmented cell size of neonatal rat cardiac myocytes induced by
myocardin, as well as the mRNA and protein levels of hypertrophic genes, whereas deletion of CArG
boxes in the atrial natriuretic factor (ANF) promoter attenuates the effect of CMV IE2 with myocar-
din. In conclusion, CMV IE2 synergistically stimulates myocardin transactivity in the hypertrophic
marker gene ANF in a CArG box-dependent manner. Our study indicates that the association of
CMV IEs with myocardin-induced transcription may be involved in myocardin-mediated cardiac
hypertrophy.
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Cardiac myocytes lose their proliferative capacity soon after
birth irreversibly with the loss of a set of fetal cardiac genes that
are normally expressed in the heart only before birth. However,
in response to stress signals, postnatal cardiomyocytes undergo
hypertrophic growth in myocyte size or myoﬁbrillar volume
without a change in myocyte number, accompanied by the
re-expression of some fetal cardiac genes [1,2]. It suggests that
the transcriptional pathway that controls cardiac gene expression
during development may be redeployed to regulate hypertrophic
cardiac growth. As a powerful regulator of cardiac gene expression,
serum response factor (SRF) was found to response to hypertrophic
signals by binding the DNA consensus sequence CC(A/T)6GG,
known as a CArG box [3]. Myocardin is a cardiac and smoothchemical Societies. Published by E
te early proteins; ANF, atrial
RF, serum response factor;
egative myocardin mutant
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Zhang).muscle speciﬁc transactivator [4] that potently transactivates CArG
box containing cardiac and smooth muscle target genes, including
atrial natriuretic factor (ANF), one of the most sensitive markers for
hypertrophic signaling [5]. Myocardin does not bind DNA alone but
forms a stable ternary complex with SRF bound to DNA [5–7]. Our
previous study shows forced expression of myocardin in isolated
cardiomyocytes induces cardiomyocyte hypertrophy, while
expression of a dominant-negative myocardin-mutant protein
blocks cardiomyocyte hypertrophic response [8].
Human cytomegalovirus (HCMV) is a ubiquitous herpes virus
that leads to a life-long persistence [9]. It is a signiﬁcant pathogen
of immunocompromised individuals, including AIDS patients,
transplant recipients, and congenitally infected neonates [10].
Smieja et al. reported CMV is associated with worsening cardiovas-
cular events in people at high risk of cardiovascular disease [11]. It
is also linked to atherosclerosis and cardiovascular diseases in
heart transplant patients [12–14]. But the possible mechanism
underlying the association of CMV and related heart diseases has
not been clariﬁed. In normal permissive cells, HCMV-encoded reg-
ulatory proteins including immediate early protein 1 (IE1) and 2
(IE2) induce cell cycle arrest and prevent cell apoptosis to favorite
replication of viral DNA. It has been shown that HCMV-infected
cells have potential pathogenicity without its virion production,lsevier B.V. All rights reserved.
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modifying expression both viral and host cellular genes, as well
as cytokines [15,16]. The IE2 protein is an essential multifunctional
protein that acts as a strong transactivator of viral and cellular pro-
moters [17–19]. Its function includes negative autoregulation of
the viral major immediate-early (MIE) promoter, transactivation
of viral and cellular promoters, inactivation of cellular cytokine
and chemokine promoters, and control of cell cycle progression.
It is likely that the interaction of host and virus protein involves
in the speciﬁc regulation mechanism of myocardin-mediated car-
diomyocyte hypertrophy.
In the present study, cytomegalovirus immediate early proteins
(CMV IEs) role in the myocardin-induced cardiac hypertrophy and
possible mechanisms were investigated. We showed that CMV IEs
enhanced myocardin-induced cardiac hypertrophy, including in-
creased expression of mRNAs and proteins of hypertrophic gene
ANF and myoﬁbrillar protein a-actinin. Co-transfection of CMV
IEs profoundly ampliﬁes the transactivity of myocardin on the
ANF promoter in neonatal cardiac myocyte. Furthermore, trunca-
tion analyses using ANF-luciferase reporter constructs showed that
A/T-rich CArG boxes of the ANF promoter, which bound SRF, was
required for co-transactivation of CMV IEs with myocardin. More-
over, a transactivation domain dominant-negative myocardin
mutant (myocardinDTAD), which retains the ability to associate
with SRF but is defective in transcriptional activation, blocks
CMV IEs induced transactivation of ANF promoter, indicating IEs’
co-transactivation effect depends, at least partly, on myocardin in
cardiac myocytes. Our studies show possible involvement of viral
protein IEs with myocardin-induced transcriptional program in
cardiac hypertrophy.2. Materials and methods
2.1. Isolation of primary neonatal rat cardiomyocytes, cell culture and
cell size measurement
All surgical procedures were approved by the Committee on the
Ethical Aspects of Research Involving Animals of Hubei Province
Experimental Animal Control Center. Neonatal rat cardiomyocytes
were prepared as described previously with minor modiﬁcation
[20]. Brieﬂy, 0- to 3-day Sprague–Dawley neonatal rat (90–100 g)
hearts were dissected, the atrial and ventricular portions were sub-
dissected, and the apical one third of the ventricle was removed for
trypsin dissociation and followed by repeated trypsinization with
stirring at 37 C in a water bath. The supernatant containing single
cells was collected every 15 min and seeded in DMEM/F12 (1:1,
Hyclone) supplemented with 15% fetal bovine serum (FBS, Hy-
clone) and penicillin/streptomycin at 37 C in humiﬁed air with
5% CO2. At the time of experiments, these cell preparations typi-
cally contain greater than 95% cardiomyocytes, as assessed by
immunohistochemical analysis with a monoclonal antibody
against a-actin (Sigma). The cultured cardiomyocytes were pooled
from 30 to 50 neonatal rat ventricles in each experiment. Cells de-
rived from the same primary culture were used for each set of
experimental comparisons. Each experiment was performed three
to four times with different primary cell isolates. Cos-7 cells were
cultured in DMEM containing 10% fetal calf serum (FCS, Hyclone),
penicillin (100 U/ml) and streptomycin (100 U/ml).
To measure the cell size, cardiomyocytes were immunostained
with anti-a-actinin antibody. Fifty cell images of cardiomyocytes
were randomly chosen from at least 20 randomly chosen ﬁelds
of each treatment (40 objective). The surface area of the cardio-
myocytes was measured in three separate experiments using a
computerized morphometric system (Image J, National Institute
of Health). The results are presented as mean ± standard deviationcompared to the control, which is assigned a value of 1. Only the
cells that were completely in the ﬁeld were measured.
2.2. Construction of ANF promoter driven luciferase and HCMV IEs
plasmids
PcDNA3.1-myocardin encoding the full-length myocardin and
pcDNA3.1-myocardinDTAD were provided by Dr. Olson of the Uni-
versity of Texas Southwestern Medical Center, which retains the
ability to associate with SRF but is defective in transcriptional acti-
vation. A set of three luciferase reporter vectors driven by different
promoter sequences of ANF were constructed in pGL-3 vector:
ANF-1000Luc, ANF-121Luc and ANF-236Luc. Three corresponding
fragment of the rat ANF region [1000 to +46, 236 to +46,
121 to +46 relative to the start of the open reading frame
(ORF)] were ampliﬁed by genomic PCR with the following primers.
ANF-1000Luc: sense, 50-AGGAACGCGTGCCTTCACGGATCACTTC-30,
and antisense, 50-TCTGCTCGAGGCTGTCTCGGCTCACTCT-30; ANF-
236Luc: sense, 50-ATCACGCGTAATGTGACTCTTGCAGCTGAGG-30,
and antisense, 50-TCTGCTCGAGGCTGTCTCGGCTCACTCT-30; ANF-
121Luc: sense, 50-TCTTACGCGTGCCGCCGCAAGTGACAG-30, and
antisense, 50-TCTGCTCGAGGCTGTCTCGGCTCACTCT-30. The ob-
tained fragments were cloned into pGL-3. These constructs contain
two (ANF-1000Luc), one (ANF-236Luc) or no CArG box in ANF pro-
moter sequence.
Human cytomegalovirus expression plasmids (CMV IE1, CMV
IE2 and CMV IE) were kindly provided by Dr. Julie A. Kerry of the
Department of Microbiology and Molecular Cell Biology, Eastern
Virginia Medical School, in which the CMV IE express both IE1
and IE2 as described previously [21].
2.3. Transient transfection and luciferase reporter assays
Cell transfection, luciferase assays were performed as described
previously [8]. Approximately 24 h before transfection, Cos-7 cells
or rat cardiomyocytes were seeded at 1.5  104 cells/cm2 onto 24-
well plates (Corning). Transfections were performed with Fugene
HD (Roche Applied Science) according to manufacturer’s instruc-
tions. Unless otherwise indicated, 100 ng of reporter and 400 ng
of activator plasmids were used. The total amount of DNA per well
was kept constant by adding the corresponding amount of expres-
sion vector without a cDNA insert. All the proteins were expressed
at a very similar level as conﬁrmed by Western blot. Thirty-six
hours after transfection, luciferase activity was measured by using
a luciferase reporter assay system (Promega) on a luminometer
(Bioteck, USA). Transfection efﬁciencies were normalized by total
protein concentrations of each luciferase assay preparations. All
experiments were performed at least three times with different
preparations of plasmids and primary cells, producing qualitatively
similar results. Data in each experiment are presented as the
mean ± standard deviation of triplicates from a representative
experiment.
2.4. Reverse transcription-polymerase chain reaction
Total RNA was isolated from cells using Trizol reagent (Invitro-
gen). cDNA was synthesized from 1 lg of total RNA in a 20 ll
reverse transcription (RT) system followed by PCR ampliﬁcation
in a 50-ll PCR system performed using an RT-PCR kit (Promega,
USA). Housekeeping gene Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was used as RNA loading control. The PCR primer
sequences are as follows – ANF: sense, 50-AGAGAGTGAGCCGAGA-
CAGC-30, and antisense, 50-TCTGAGACGGGTTGACTTCC-30; a-acti-
nin: sense, 50-ATTGGTATGGAGTCTGCCG-30, and antisense, 50-TC
CTGAGTGTAAGGTAGCCG-30. The PCR were conducted according
to manufacturer’s instruction and the PCR products were
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1084 J. Zhou et al. / FEBS Letters 585 (2011) 1082–1088analyzed by agarose gel electrophoresis. Gels were photographed
and densities of the bands were determined with a computerized
image analysis system (Alpha Innotech, San Leandro, CA). The area
of each band was calculated as the integrated density value (IDV).
Mean values were calculated from three separate experiments. The
IDV ratios of ANF to GAPDH and a-actinin to GAPDH were calcu-
lated for each sample.
2.5. Western blotting
Thirty-six hours following transfection, cell protein extracts
were prepared in lysis buffer and protein concentrations were
determined by using the BCA protein assay kit. Western blotting
analysis was performed essentially as described previously [22].
The speciﬁc proteins were visualized using ECL Chemilumines-
cence reagent (Millipore). The primary antibodies ANF (Abcam)
and a-actinin (Sigma) were used for blotting.
2.6. Immunoﬂuorescence microscopy
Cultured cells were ﬁxed in 4% paraformaldehyde at room
temperature for 15 min, followed by 0.3% Triton X-100 incuba-
tion at room temperature for 10 min. Cells were washed with
PBS, blocked with goat serum at 1:20 for 20 min and then incu-
bated with rabbit primary anti-ANF Ab and a-actinin (1:100;
Sigma) overnight, followed by FITC-conjugated Ab to rabbit
IgG. Nuclei were stained with 2 lg/ml of 40,6-diamidino-2-phen-
ylindole (DAPI). Images were visualized and captured with a
ﬂuorescence microscope.A
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Fig. 1. CMV IE2 increased myocardin’s transcriptional activity on ANF promoter.
Increasing concentrations of plasmids expressing CMV IE2 were co-transfected with
myocardin expressing plasmid. The vector plasmid pcDNA3.1 of myocardin
construct was used as control. (A) The effects in cos-7 cells; (B) the effects in rat
neonatal cardiomyocytes.3. Results and discussion
As a lot of evidences have shown CMV IEs’ transcription activi-
ties in host cell genes expression [17,19,23,24] and the association
of CMV infection with cardiovascular diseases [11–14], mecha-
nisms underlying CMV IE transcriptional regulation and the relatedB
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Fig. 2. CMV IE2 elevated myocardin-induced ANF and a-actinin expression. (A) The
representative image showed the upregulation of ANF and a-actinin mRNA
expression by co-transfection of myocardin and CMV IEs in neonatal rat cardio-
myocytes. Total RNAs were isolated and the expression of ANF and a-actinin were
examined by semiquantitative RT-PCR. GAPDH was used to serve as a loading
control. The intensity of PCR products on the agarose gel image was quantiﬁed
using the Photoshop Histogram Analysis and was plotted using Microsoft Excel.
Data were shown as relative expression level after being normalized by GAPDH. Bar
graph shows the mean level of at least two experiments. (B) Upregulation of ANF
and a-actinin protein expression by co-transfection of myocardin and CMV IEs in
neonatal rat cardiomyocytes. Cells transfected with pcDNA3.1 are served as control.
Total proteins were extracted, and the protein levels were detected by Western blot
analysis. b-Actin was used as a loading control. The intensity of protein products
was quantiﬁed using the Photoshop Histogram Analysis and was plotted using
Microsoft Excel. Data were shown as relative expression level after being normal-
ized by b-actin. Bar graph shows the mean level of at least three experiments.
Statistical differences were determined using the Student t-test: ⁄P < 0.05,
⁄⁄P < 0.01, compared with myocardin transfected cells.
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Fig. 3. The effects of CMV IEs and myocardin on cardiomyocytes size, a-actinin and ANF expression. (A) Representative images of immunostained cardiomyocyte cultures
transfected with each of the indicated constructs. The left panels (green) show anti-a-actinin antibody reactivity to demonstrate cardiomyocyte sarcomeres and gross
morphology. The middle panels (blue) show the DAPI staining for nuclei. The right panels show double immunostained for a-actinin and nuclei. Scale = 70 lm. (B) Cell surface
area measurements in cardiomyocytes transfected with CMV IEs and/or myocardin. The results were presented as mean ± S.E. compared with the control, which is assigned a
value of 1. n = 50. The ﬁrst bar shows the value of cells transfected with pcDNA3.1. Statistical differences were determined using the Student t-test: ⁄P < 0.05, ⁄⁄P < 0.01. (C)
Induction of cardiomyocyte hypertrophy by myocardin. Primary neonatal cardiomyocytes were transfected with myocardin, IEs respectively or co-transfected with
myocardin and IEs. Two days later, cultures were ﬁxed and stained with antibodies for ANF (which appears in a perinuclear pattern). PcDNA3.1 transfected cardiomyocytes
were used as control.
J. Zhou et al. / FEBS Letters 585 (2011) 1082–1088 1085cardiovascular diseases still require elucidation. The data in this
study connect the role of CMV IE proteins to the cardiac and
smooth muscle cell (SMC) speciﬁc transcription factor-myocardin
in the transcription regulation of hypertrophic gene-ANF of host
cell.
3.1. CMV IE2 increased myocardin’s transcriptional activity on ANF
promoter
Previous study has shown myocardin functions as transactiva-
tor of one of the hypertrophic marker genes-ANF, which is depen-
dent on the binding of SRF and CArG boxes located on ANF
promoter. Myocardin also directly induce cardiac hypertrophy,
on the other hand, induced cardiac hypertrophy increases the
expression of myocardin [8]. To determine whether CMV immedi-
ate early genes are involved in myocardin-mediated hypertrophy,
we observed the activation effect of ANF promoter after co-trans-
fecting myocardin and CMV IE2 in Cos-7 cells and primary neona-
tal rat cardiomyocytes. As shown in Fig. 1A and B, co-expression of
IE2 with myocardin in both cells signiﬁcantly enhanced the myo-
cardin’s transactivating effect on ANF promoter from 30 folds to
over 100 folds compared to myocardin alone (P < 0.01). FollowingDNA increase of IE2 plasmid by two to four folds the ANF pro-
moter’s transactivation effects appeared to further increase. The
results show that HCMV IE2 positively regulates the transcriptional
activity of myocardin.
3.2. CMV IE2 elevated myocardin-induced ANF and a-actinin
expression
To explore the effect of CMV IEs on the expression of myocardial
hypertrophy related genes induced by myocardin, we observed the
mRNA and protein levels of hypertrophic gene-ANF and sarcomeric
a-actinin in primary cardiomyocytes co-transfected with CMV IEs
and myocardin. RNA and protein loading controls were evaluated
by mRNA level of GAPDH and protein expression level of b-actin.
As shown in Fig. 2A and B, CMV IEs alone could stimulate a-acti-
nin’s protein expression but have very weak or no activity in ANF’s
mRNA and protein expression, however, increased levels of mRNA
for ANF and a-actinin were apparently observed in cultured
myocardial cells co-transfected with CMV IE2 and myocardin.
Band-density analysis conﬁrmed the strong amplifying effect of
IE2 on myocardin-mediated ANF and a-actinin expression, which
increased the mRNA and protein levels of ANF by over eight folds,
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Fig. 4. Transactivating effects of HCMV IEs on myocardin-induced ANF promoter
activities in cos-7 cells and neonatal rat cardiomyocytes. Cells were transfected
with the luciferase reporter (ANF-Luc) and indicated expression plasmids for
myocardin and CMV IEs. Thirty-six hours later, cells were harvested and luciferase
activities were measured 36 h after transfection. Values are normalized as the fold
increase in luciferase activity in the presence of expression plasmids above the level
of activity with reporter plasmid and pcDNA3.1. All experiments were repeated
three times in duplicate. (A) Luciferase assay in cos-7 cells; (B) luciferase assay in
neonatal rat cardiomyocytes.
1086 J. Zhou et al. / FEBS Letters 585 (2011) 1082–1088a-actinin by nearly four folds. Taken together, the results demon-
strated that CMV IE2 synergistically promotes myocardin-induced
expression of hypertrophic marker genes ANF and a-actinin.
3.3. CMV IEs augmented cardiomyocyte hypertrophy-mediated by
myocardin
We have previously shown that myocardin can directly induce
myocardial hypertrophy. On the other hand, induced cardiac
hypertrophy increases the expression of myocardin [8]. In this
study, we observed that the hypertrophic effect of myocardin can
be enhanced by CMV IEs, especially IE2, as shown in Fig. 3A. In cul-
tured cardiomyocytes, the immunoﬂuorescent staining indicated
that the myocardin hypertrophy induction with the co-expression
of CMV IEs was accompanied by elevated expression of ANF (3C),
cellular enlargement (3B) and disorganization of sarcomeres (3A)
which was revealed by the a-actinin staining. The intensity of
ANF induction by co-expression of IEs and myocardin was upregu-
lated comparably to that induced by myocardin alone (Fig. 3C,
compare a with b, c and d).
Cardiomyocyte surface area was measured to determine the ex-
tent of hypertrophy. Cell surface area was increased two to four
folds following IE2 co-transfection, as compared with myocytes
transfected with myocardin alone, which was statistically signiﬁ-
cant (Fig. 3B). In contrast, cardiomyocytes transfected with CMV
IE1 showed no signs of cell size enlargement. Other changes asso-
ciated with myocardin and CMV IEs co-transfection include an
increased rate of spontaneous beating as well as an enhanced
aggregation of cardiomyocytes in prolonged culture (data not
shown). These observations suggest that CMV IE proteins may
directly up-regulate myocardin-mediated cardiomyocyte hyper-
trophy.
3.4. Different transactivating effects of HCMV IEs on ANF promoter in
Cos-7 and primary myocardial cells
To investigate whether both HCMV IE1 and IE2 proteins have
the same transactivating effect on hypertrophic marker gene ANF
promoter, we respectively co-transfected HCMV IE, IE1 and IE2
with myocardin in both Cos-7 cells and primary neonatal rat
cardiomyocytes. As shown in Fig. 4A and B, the HCMV IE2’s effect
is much more apparent than IE1 and IE in both cells (P < 0.01),
which is consistent with the hypertrophic induction effect de-
scribed above. It seems that HCMV IE2’s effect is reduced by IE1
since HCMV IE construct which expresses both IE1 and IE2 induces
less luciferase expression than HCMV IE2 alone. Likewise, in Figs. 2
and 3, the hypertrophic genes’ mRNA and protein levels, and the
enlargement of cardiac cells induced by IE with myocardin were
signiﬁcant lower than by IE2 alone.
3.5. The synergistic transactivation effect of CMV IEs and myocardin on
ANF is dependent on CArG box sequences located at ANF promoter
To determine whether the CArG boxes in ANF promoter was
sufﬁcient to confer the transcriptional responsiveness to myocar-
din and CMV IEs, we tested luciferase activities driven by the
two mutated ANF promoters, which were deleted one or two
CArG sequences (Fig. 5A). As shown in Fig. 5B and C, myocardin’s
expression in both cells activated the luciferase gene’s expres-
sion driven by wild type ANF promoter (ANF-1000), whereas
CMV IE2 by itself does not have the same effect. However, after
co-transfecting with myocardin in the two cells, CMV IE2 greatly
enhanced the myocardin’s transactivation effect by over three
times, from 30 folds to over 100 folds (Fig. 5B and C, the blank
bars). CMV IE and CMV IE1 have slight effect. Moreover, as
shown in Fig. 5B and C, deletion of distal CArG box in ANF-236 severely reduced transcriptional activity of myocardin
(Fig. 5B and C, the black bars) and deletion of both CArG boxes
in ANF promoters (ANF-121) was hardly respond to myocardin
in both cells (Fig. 5B and C, the bars with wavy pattern). This re-
sults are similar to Xing’s report [8] in which single base muta-
tion in CArG sequences of ANF promoter reduced or eliminated
myocardin’s activities. At the same time, the IE2’s co-transcrip-
tional effect with myocardin was decreased by nearly 50% for
ANF-236, and the promoter ANF-121 with both CArG boxes de-
leted has slight respond to myocardin and/or IEs.
3.6. Myocardin is necessary in hypertrophic gene ANF’s expression
Moreover, a dominant-negative myocardin mutant (myocar-
dinDTAD which lacks its TAD domain, residues 713–935) and re-
tains the ability to associate with SRF but is defective in
transcriptional activation, were used to further testify whether
myocardin is necessary in luciferase reporter gene’s expression un-
der HCMV IE2’s effect. The result showed compared with wild type
myocardin, co-expression of myocardinDTAD and IE2 signiﬁcantly
reduced luciferase’s expression driven by ANF promoter in both
Cos-7 cell and neonatal rat cardiomyocyte (Fig. 6A and B). However
interestingly, co-expression of IE2 and myocardinDTAD still can
partly stimulate transactivity of ANF promoter, which is not ob-
served when expresses IE2 or myocardinDTAD alone. Taken to-
gether, these results showed that forced co-expression of
myocardin and CMV IE2, which respectively generated from host
cell and viral particle, stimulates much more potent transactiva-
tion effect of ANF promoter than myocardin.
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Fig. 5. The synergistic transactivation effects of CMV IE2 and myocardin on the
CArG box mutants of ANF promoters in neonatal rat cardiomyocytes. (A)
Constructions of 50 deletions of rat ANF promoters. A set of three reporter vectors
were constructed, including a construct composed of 121 bp of rat ANF promoter
driving luciferase reporter gene (ANF-121Luc) without CArG box, a construct
composed of 236 bp of rat ANF driving luciferase reporter with one CArG box and a
construct composed of 1000 bp of rat ANF promoter driving luciferase reporter with
two CArG boxes (wild type). (B) Luciferase reporter activities driven by the three
ANF promoters after over-expression of myocardin, dominant negative myocardin
and CMV IE2 in cos-7 cells. (C) Luciferase reporter activities driven by the three ANF
promoters after over-expression of myocardin, dominant negative myocardin and
CMV IE2 in neonatal rat cardiomyocyte.
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Fig. 6. Myocardin is necessary in luciferase reporter gene ANF-Luc expression. Cells
were transfected with luciferase reporter plasmid ANF-Luc, wild type myocardin or
a dominant-negative myocardin mutant (myocardinDTAD which lacks its TAD
domain, residues 713–935) and/or IE2. Values were normalized as the fold increase
in luciferase activity with the presence of expression plasmids above the level of
activity with reporter plasmid and pcDNA3.1. All experiments were repeated three
times in duplicate. (A) ANF-Luc expression in cos-7 cells. (B) ANF-Luc expression in
rat neonatal cardiomyocyte.
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duce myocyte hypertrophy, as a dominant negative myocardin
mutant prevents ANF promoter’s activity with co-transfection of
CMV IEs and myocardin. Moreover, our results implied that CMV
IE2’s function was attenuated even eliminated by CMV IE1 since
CMV IE which expresses both proteins did not appear similar effect
as CMV IE2.
In summary, our results demonstrated that HCMV IE2 protein,
introduced by gene transfection, enhances myocardin-mediated
cardiac hypertrophy, which is, at least partially, dependent on
CArG box sequence located on the promoter of hypertrophic mar-
ker gene-ANF. As myocardin forms a ternary complex with SRF
bound to DNA, viral proteins expression in cardiac myocytes may
inﬂuence SRF/myocardin’s regulation of cardiac genes. It is possible
that HCMV IE1 and IE2 modulate the expression of host genes-ANF
and a-actinin via different mechanisms, since the results shown
here suggest different effects of IE1 and IE2 on myocardin’s
transactivity.Reports have shown that myocardin’s expression is upregulated
in cytokines leukemia inhibitory factor (LIF), IL-6 and angiotensin-
II-stimulated cardiac hypertrophy [25]. While HCMV IE proteins
have been reported to modulate the cellular expression of onco-
genes [26] and cytokines [15,16]. Therefore, it is intriguing to spec-
ulate that HCMV IE2 protein may accelerate some cytokines-
induced cardiomyocyte hypertrophy. On the other hand, the direct
protein–protein interaction of HCMV IEs and myocardin also could
facilitate myocardin-mediated hypertrophy. This study ﬁnds a no-
vel host cell gene-myocardin targeted by HCMV virus IE proteins,
which may stimulate multiple cellular functions of myocardin,
including cardiomyocyte development, proliferation and differen-
tiation. The molecular mechanisms underlying the protein–protein
interaction of myocardin and HCMV IE proteins, or the regulation
of cytokines by myocardin and virus products need to be further
explored.
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